BUSINESS
Diagnostics: Time to look at this quasi-consumer industry
A bigger landscape of opportunity awaits organised diagnostic chains to increase market share
BUSINESS
Discovery Series: Krsnaa Diagnostics -- Multiple catalysts at work
Business fundamentals look solid and the growth potential is very promising
BUSINESS
Coromandel International marks strategic entry into new growth segments
A stock well positioned to benefit from the growth potential in agrochemical/industrial chemical space
BUSINESS
A hospital stock with best-in-class operating numbers, growth template
Aggressive long-term expansion plans are in place with brownfield projects to be margin accretive for Max Healthcare in the near term
BUSINESS
Be selective in agrochemical space as monsoon remains the joker in the pack
There are a few business models which are better placed to ride this period of weather uncertainty but caution needs to be exercised
BUSINESS
Dhanuka Agritech: Growth catalysts go missing
Weak 9M performance and limited opportunities for a turnaround continue to exert pressure on margins
BUSINESS
Sumitomo Chemical India: Long-term opportunity despite near-term headwinds
Opportunity to supply technicals to its parent company showcases export potential, but near-term risks prevail
BUSINESS
PI Industries: Our optimism remains intact
A company with superior execution and solid business model
BUSINESS
Apollo Hospitals: A credible profitability road map for pharmacy is the ask
Margin improvement continued in the mature hospitals division, but Apollo 24/7’s operating cost weighed on EBITDA
BUSINESS
Global Health: Faster ramp-up in new facilities adds to financial health
Strong ramp-up in its newer facilities reflect the growing demand for high-end institutional healthcare facilities
BUSINESS
UPL — Limited visibility on debt reduction targets
Corporate realignment has generated investor interest, but lowering debt is a prerequisite for rerating
BUSINESS
KIMS: Ramp-up of newly acquired entities to be key growth driver
KIMS presents a play on the structural demand trend for healthcare facilities
BUSINESS
Paradeep Phosphate: Watch out for volume uptick, backward integration
FY24/25 to see backward integration efficiencies kick in. Growth plan is right in place
BUSINESS
Coromandel International: The value case for this stock is shaping up well
A stock well positioned to benefit from growing and continually evolving agri-input space
BUSINESS
Sharda Cropchem: Why are we turning positive?
Near-term positive outlook and attractive valuations create room for stock upside
BUSINESS
Rallis India: A stock for the next year?
We see an improvement in Rallis’ business in FY24 and view the recent correction as an opportunity to accumulate for long-term gains
BUSINESS
Agri-input sector: Will it get the much-needed boost from the Budget 2023?
Any development that improves affordability to farmers will augur well for agri-input demand and benefit manufacturers
BUSINESS
UPL: Wait for the right key to open stock re-rating door
The stock's current valuation is at a discount to its long-term historical average and remains inexpensive, compared to its peers
BUSINESS
Paradeep Phosphate: New capacity creates window for growth
BUSINESS
Dharmaj Crop Guard: Should you apply for this IPO?
Long-term performance and re-rating of this stock depends on successful execution of the planned projects
BUSINESS
Dhanuka Agritech: Buyback doesn’t make us a buyer of this stock
Margin pressure remains extended, near-term growth triggers remain limited
BUSINESS
PI Industries: Standing strong in testing times
PI’s superior execution with a solid business model accompanied with surplus cash and backward integration strategies makes it a perfect stock to be bought on declines
BUSINESS
Coromandel International: There is a long-term value case for this stock
We resume coverage on Coromandel, with a recommendation to accumulate the stock for long-term gains
BUSINESS
Archean Chemical: Company plans to clean balance sheet through IPO
Archean Chemical had a checkered history in terms of debt management and struggled to execute its expansion plan one time. A successful IPO, however, can provide a clean slate this time to foray into bromine derivatives
